A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Clinical trial NCT07076199 · RECRUITING
Trial details
- NCT number
- NCT07076199
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2027-01-25
- Enrollment
- 877
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.